Oral Semaglutide
A daily pill form of semaglutide, the same GLP-1 receptor agonist as the injectable, approved for chronic weight management and launched in January 2026. Absorption depends on strict fasted dosing.
- Half-life
- 7.0 d
- Out of system
- ~5 weeks
- Route
- Oral
- Level
- Beginner
Long-acting — weekly dosing keeps levels steady. After the last dose, roughly 97% has cleared in ~5 weeks (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What Oral Semaglutide is used for
- Provides semaglutide's proven appetite control and weight loss without injections
- Approved for chronic weight management with an established safety record for the molecule
- A daily pill may suit people who prefer to avoid weekly self-injection
How it's typically used
Label range: 25 mg once daily taken fasted, following the approved titration schedule reported in the literature.
What to watch for
- Requires strict fasted dosing with a small sip of water and a wait before eating, or absorption fails
- GI side effects and GLP-1 class thyroid and gallbladder warnings apply
- Prescription medication (approved and launched January 2026); use only under medical supervision
About GLP-1 & weight loss
- What they are
- Incretin analogues — GLP-1 and dual/triple agonists. They slow stomach emptying and act on appetite centres in the brain, so you eat less without white-knuckling it.
- How they're run
- One subcutaneous shot a week for most, on the same day each week. Doses climb in steps every four weeks; that slow titration is what keeps side effects tolerable.
- What to watch
- Nausea, constipation, and reflux are near-universal in the first month. Muscle is lost alongside fat unless you keep protein high and keep lifting. Tell any surgeon or anaesthetist you are on one.
Full guide
Oral Semaglutide 25 mg: A Tracking Guide for the Wegovy Pill
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
Other glp-1 & weight loss
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.